This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignees: Biomerieux Vitek, Inc., Biomerieux, Inc., Amoco Corporation. Active years: 1998-2007.
Location History:
- Farmingham, MA (US) (2003)
- Framingham, MA (US) (1998 - 2007)
- Franklin, MA (US) (2007)
Company Filing History:
4 out of 31 
2 out of 645 
1 out of 1,528 Years Active: 1998-2007
Title: J Lawrence Burg: Innovator in Nucleic Acid Assays
Introduction
J Lawrence Burg is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of nucleic acid detection, holding a total of 7 patents. His work focuses on improving the accuracy and efficiency of nucleic acid assays, which are crucial in various scientific and medical applications.
Latest Patents
Burg's latest patents revolve around the automation and enhancement of nucleic acid assays. One of his inventions relates to the detection of specific nucleic acid sequences after an amplification process or directly without amplification. This invention emphasizes the automation of both the amplification and detection processes, incorporating internal controls to minimize contamination risks. Another patent further improves the compositions and methods for reducing contamination during reagent manipulation, while also utilizing automated apparatus for the detection of amplified nucleic acid sequences.
Career Highlights
Throughout his career, J Lawrence Burg has worked with prominent companies such as bioMérieux Vitek, Inc. and bioMérieux, Inc. His expertise in the field has allowed him to develop innovative solutions that enhance the reliability of nucleic acid testing.
Collaborations
Burg has collaborated with notable professionals in his field, including Luigi Catanzariti and James G Moe. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
J Lawrence Burg's contributions to nucleic acid assays demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of the challenges in nucleic acid detection and a dedication to improving assay performance.